Aspirin and dipyridamole in the prevention of coronary disease and coronary artery bypass graft occlusion

Editorial

B H Chong. Aust N Z J Med. 1992 Dec.

. 1992 Dec;22(6):645-6.

doi: 10.1111/j.1445-5994.1992.tb04863.x.

No abstract available

Similar articles

Effect of dipyridamole and aspirin on vein graft patency after coronary bypass operations.
Chesebro JH. Chesebro JH. Thromb Res Suppl. 1990;12:5-10. doi: 10.1016/0049-3848(90)90433-d. Thromb Res Suppl. 1990. PMID: 2082487 Clinical Trial.
Prevention of graft occlusion by aspirin, dipyridamole, and oral anticoagulants.
Loeliger EA. Loeliger EA. Lancet. 1993 Sep 25;342(8874):806; author reply 807. Lancet. 1993. PMID: 8103893 No abstract available.
Prevention of graft occlusion by aspirin, dipyridamole, and oral anticoagulants.
Houben JJ, Nicolai G. Houben JJ, et al. Lancet. 1993 Sep 25;342(8874):806-7. Lancet. 1993. PMID: 8103894 No abstract available.
Aspirin for the prevention of coronary thrombosis: current facts and perspectives.
Patrono C. Patrono C. Eur Heart J. 1986 Jun;7(6):454-9. doi: 10.1093/oxfordjournals.eurheartj.a062091. Eur Heart J. 1986. PMID: 3525167 Review. No abstract available.
Platelet-inhibitor drugs before and after coronary artery bypass surgery and coronary angioplasty: the basis of their use, data from animal studies, clinical trial data, and current recommendations.
Chesebro JH, Fuster V. Chesebro JH, et al. Cardiology. 1986;73(4-5):292-305. doi: 10.1159/000174022. Cardiology. 1986. PMID: 2944585 Review.